244 related articles for article (PubMed ID: 30558294)
1. Looking at Marine-Derived Bioactive Molecules as Upcoming Anti-Diabetic Agents: A Special Emphasis on PTP1B Inhibitors.
Ezzat SM; Bishbishy MHE; Habtemariam S; Salehi B; Sharifi-Rad M; Martins N; Sharifi-Rad J
Molecules; 2018 Dec; 23(12):. PubMed ID: 30558294
[TBL] [Abstract][Full Text] [Related]
2. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
[TBL] [Abstract][Full Text] [Related]
3. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
Nandi S; Saxena M
Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
[TBL] [Abstract][Full Text] [Related]
4. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
5. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
[No Abstract] [Full Text] [Related]
7. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
[TBL] [Abstract][Full Text] [Related]
8. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity.
Rocha RF; Rodrigues T; Menegatti ACO; Bernardes GJL; Terenzi H
Bioorg Chem; 2020 Jul; 100():103927. PubMed ID: 32422389
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus.
Panzhinskiy E; Ren J; Nair S
Curr Med Chem; 2013; 20(21):2609-25. PubMed ID: 23627940
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
11. Small molecules as potent protein tyrosine phosphatase 1B (PTP1B) inhibitors documented in patents from 2009 to 2013.
Wang LJ; Jiang B; Wu N; Wang SY; Shi DY
Mini Rev Med Chem; 2015; 15(2):104-22. PubMed ID: 25643610
[TBL] [Abstract][Full Text] [Related]
12. Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update.
Liu Z; Gao H; Zhao Z; Huang M; Wang S; Zhan J
Biomed Pharmacother; 2023 Jan; 157():113990. PubMed ID: 36459712
[TBL] [Abstract][Full Text] [Related]
13. [Search for Protein Tyrosine Phosphatase 1B Inhibitors from Marine Organisms and Induced Production of New Fungal Metabolites by Modulating Culture Methods].
Yamazaki H
Yakugaku Zasshi; 2019; 139(5):663-672. PubMed ID: 31061333
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
Jiang B; Luo J; Guo S; Wang L
Bioorg Chem; 2021 Mar; 108():104648. PubMed ID: 33493928
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics.
Agrawal N; Dhakrey P; Pathak S
Chem Biol Drug Des; 2023 Oct; 102(4):921-938. PubMed ID: 37232059
[TBL] [Abstract][Full Text] [Related]
16. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes.
Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z
Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946
[TBL] [Abstract][Full Text] [Related]
17. α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitory Activity of Plastoquinones from Marine Brown Alga Sargassum serratifolium.
Ali MY; Kim DH; Seong SH; Kim HR; Jung HA; Choi JS
Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194348
[No Abstract] [Full Text] [Related]
18. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
[TBL] [Abstract][Full Text] [Related]
19. Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus.
Prabhakar PK; Sivakumar PM
Curr Pharm Des; 2019; 25(23):2526-2539. PubMed ID: 31333090
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
Liu P; Du Y; Song L; Shen J; Li Q
Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
